Curis (CRIS) Non-cash Items (2010 - 2026)
Curis' (CRIS) quarterly Non-cash Items came in at $15.2 million in Q1 2026, up 351.78% YoY from $3.4 million in Q1 2025, and up 159.07% on a QoQ basis from -$25.7 million in Q4 2025.
Curis (CRIS) Non-cash Items (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Non-cash Items data on file, last reported at $15.2 million in Q1 2026.
- Quarterly Non-cash Items rose 351.78% year-over-year to $15.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.8 million (down 191.1% YoY) and the FY2025 annual result came in at -$19.6 million, down 612.78% from the prior year.
- Non-cash Items rose to $15.2 million in Q1 2026, from -$25.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $15.2 million in Q1 2026 to a low of -$25.7 million in Q4 2025.
- A 5-year average of $630529.4 and a median of $668000.0 in 2024 frame the typical range for Non-cash Items.
- Annual changes were most pronounced in 2023 — Non-cash Items surged 2225.58% — and 2025, when it sank 7286.31%.
- Tracing CRIS's Non-cash Items over 5 years: stood at -$939000.0 in 2022, then jumped by 262.51% to $1.5 million in 2023, then slumped by 76.54% to $358000.0 in 2024, then slumped by 7286.31% to -$25.7 million in 2025, then surged by 159.07% to $15.2 million in 2026.
- The last three Non-cash Items figures came in at $15.2 million (Q1 2026), -$25.7 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Curis | 3.44 Mn | -2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.20 Mn |
| Mar 31, 2026 | 15.20 Mn |
| Dec 31, 2025 | -25.73 Mn |
| Dec 31, 2025 | -25.73 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 3.36 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 358,000.00 |
| Dec 31, 2024 | 358,000.00 |
| Sep 30, 2024 | 4.16 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 668,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Dec 31, 2023 | 1.53 Mn |